PDCD4 and urinary bladder carcinoma: Accumulating evidence has elucidated that PDCD4 could exert antitumor activity in a variety of cancer types, such as bladder cancer [29], colon carcinoma [30] and oropharyngeal cancer [31], via different regulatory pathways.